Secondary structure and dynamics of micelle bound β- and γ-synuclein

Protein Science

Volumn 15, Issue 5, 2006, Pages 1162-1174

  Sung, Yoon Hui ^a   Eliezer, David ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Amyloid; Membrane proteins; Parkinson's; Protein aggregation; Synuclein

Indexed keywords

BETA SYNUCLEIN; GAMMA SYNUCLEIN; LIPID BINDING PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPARATIVE STUDY; MICELLE; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN STRUCTURE; PROTEIN VARIANT; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; BETA-SYNUCLEIN; CIRCULAR DICHROISM; ESCHERICHIA COLI; GAMMA-SYNUCLEIN; LIPID METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 33646156188     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.051803606     Document Type: Article

References (67)

1. Abeliovich, A., Schmitz, Y., Farinas, I., Choi-Lundberg, D., Ho, W.H., Castillo, P.E., Shinsky, N., Verdugo, J.M., Armanini, M., Ryan, A., et al. 2000. Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25: 239-252.
2. Akopian, A.N. and Wood, J.N. 1995. Peripheral nervous system-specific genes identified by subtractive cDNA cloning. J. Biol. Chem. 270: 21264-21270.
3. Bisaglia, M., Tessari, I., Pinato, L., Bellanda, M., Giraudo, S., Fasano, M., Bergantino, E., Bubacco, L., and Mammi, S. 2005. A topological model of the interaction between α-synuclein and sodium dodecyl sulfate micelles. Biochemistry 44: 329-339.
4. Bradbury, J. 2003. α-Synuclein gene triplication discovered in Parkinson's disease. Lancet Neurol. 2: 715.
5. Brenz Verca, M.S., Bahi, A., Boyer, F., Wagner, G.C., and Dreyer, J.L. 2003. Distribution of α- and γ-synucleins in the adult rat brain and their modification by high-dose cocaine treatment. Eur. J. Neurosci. 18: 1923-1938.
6. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C.M., and Stefani, M. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507-511.
7. Buchman, V.L., Hunter, H.J., Pinon, L.G., Thompson, J., Privalova, E.M., Ninkina, N.N., and Davies, A.M. 1998. Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system. J. Neurosci. 18: 9335-9341.
8. Bussell Jr., R. and Eliezer, D. 2003. A structural and functional role for 11-mer repeats in α-synuclein and other exchangeable lipid binding proteins. J. Mol. Biol. 329: 763-778.
9. _. 2004. Effects of Parkinson's disease-linked mutations on the structure of lipid-associated α-synuclein. Biochemistry 43: 4810-4818.
10. Bussell Jr., R., Ramlall, T.F., and Eliezer, D. 2005. Helix periodicity, topology, and dynamics of membrane-associated α-synuclein. Protein Sci. 14: 862-872.
11. Cabin, D.E., Shimazu, K., Murphy, D., Cole, N.B., Gottschalk, W., McIlwain, K.L., Orrison, B., Chen, A., Ellis, C.E., Paylor, R., et al. 2002. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking α-synuclein. J. Neurosci. 22: 8797-8807.
12. Chandra, S., Chen, X., Rizo, J., Jahn, R., and Sudhof, T.C. 2003. A broken α-helix in folded α-synuclein. J. Biol. Chem. 278: 15313-15318.
13. Chandra, S., Fornai, F., Kwon, H.B., Yazdani, U., Atasoy, D., Liu, X., Hammer, R.E., Battaglia, G., German, D.C., Castillo, P.E., et al. 2004. Double-knockout mice for α- and β-synucleins: Effect on synaptic functions. Proc. Natl. Acad. Sci. 101: 14966-14971.
14. Conway, K.A., Harper, J.D., and Lansbury, P.T. 1998. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat. Med. 4: 1318-1320.
15. Conway, K.A., Lee, S.J., Rochet, J.C., Ding, T.T., Williamson, R.E., and Lansbury Jr., P.T. 2000. Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. 97: 571-576.
16. Davidson, W.S., Jonas, A., Clayton, D.F., and George, J.M. 1998. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273: 9443-9449.
17. Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. 1995. NMRPipe: A multidimensional spectral processing system based on UNIX pipes. [see comments] J. Biomol. NMR 6: 277-293.
18. Dosset, P., Hus, J.C., Blackledge, M., and Marion, D. 2000. Efficient analysis of macromolecular rotational diffusion from heteronuclear relaxation data. J. Biomol. NMR 16: 23-28.
19. Eliezer, D., Yao, J., Dyson, H.J., and Wright, P.E. 1998. Structural and dynamic characterization of partially folded states of apomyoglobin and implications for protein folding. Nat. Struct. Biol. 5: 148-155.
20. Eliezer, D., Kutluay, E., Bussell Jr., R., and Browne, G. 2001. Conformational properties of α-synuclein in its free and lipid-associated states. J. Mol. Biol. 307: 1061-1073.
21. Farrer, M., Kachergus, J., Forno, L., Lincoln, S., Wang, D.S., Hulihan, M., Maraganore, D., Gwinn-Hardy, K., Wszolek, Z., Dickson, D., et al. 2004. Comparison of kindreds with parkinsonism and α-synuclein genomic multiplications. Ann. Neurol. 55: 174-179.
22. Feany, M.B. and Bender, W.W. 2000. A Drosophila model of Parkinson's disease. Nature 404: 394-398.
23. Galvin, J.E., Uryu, K., Lee, V.M., and Trojanowski, J.Q. 1999. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains α-, β-, and γ-synuclein. Proc. Natl. Acad. Sci. 96: 13450-13455.
24. Galvin, J.E., Giasson, B., Hurtig, H.I., Lee, V.M., and Trojanowski, J.Q. 2000. Neurodegeneration with brain iron accumulation, type 1 is characterized by α-, β-, and γ-synuclein neuropathology. Am. J. Pathol. 157: 361-368.
25. George, J.M. 2002. The synucleins. Genome Biol. 3: reviews3002.1-3002.6.
26. Hashimoto, M., Rockenstein, E., Mante, M., Mallory, M., and Masliah, E. 2001. β-Synuclein inhibits α-synuclein aggregation: A possible role as an anti-parkinsonian factor. Neuron 32: 213-223.
27. Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., de Silva, H.A., Kittel, A., and Saitoh, T. 1995. The precursor protein of non-A β component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14: 467-475.
28. Jakes, R., Spillantini, M.G., and Goedert, M. 1994. Identification of two distinct synucleins from human brain. FEBS Lett. 345: 27-32.
29. Jao, C.C., Der-Sarkissian, A., Chen, J., and Langen, R. 2004. Structure of membrane-bound α-synuclein studied by site-directed spin labeling. Proc. Natl. Acad. Sci. 101: 8331-8336.
30. Jenco, J.M., Rawlingson, A., Daniels, B., and Morris, A.J. 1998. Regulation of phospholipase D2: Selective inhibition of mammalian phospholipase D isoenzymes by α- and β-synucleins. Biochemistry 37: 4901-4909.
31. Jensen, P.H., Hager, H., Nielsen, M.S., Hojrup, P., Gliemann, J., and Jakes, R. 1999. α-Synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J. Biol. Chem. 274: 25481-25489.
32. Ji, H., Liu, Y.E., Jia, T., Wang, M., Liu, J., Xiao, G., Joseph, B.K., Rosen, C., and Shi, Y.E. 1997. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res. 57: 759-764.
33. Johnson, B.A. and Blevins, R.A. 1994. NMRView: A computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4: 603-614.
34. Kim, T.D., Paik, S.R., and Yang, C.H. 2002. Structural and functional implications of C-terminal regions of α-synuclein. Biochemistry 41: 13782-13790.
35. Krueger-Koplin, R.D., Sorgen, P.L., Krueger-Koplin, S.T., Rivera-Torres, I.O., Cahill, S.M., Hicks, D.B., Grinius, L., Krulwich, T.A., and Girvin, M.E. 2004. An evaluation of detergents for NMR structural studies of membrane proteins. J. Biomol. NMR 28: 43-57.
36. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L., and Riess, O. 1998. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18: 106-108.
37. Lavedan, C., Leroy, E., Dehejia, A., Buchholtz, S., Dutra, A., Nussbaum, R.L., and Polymeropoulos, M.H. 1998. Identification, localization and characterization of the human γ-synuclein gene. Hum. Genet. 103: 106-112.
38. Lipari, G. and Szabo, A. 1982a. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity. J. Am. Chem. Soc. 104: 4546-4559.
39. _. 1982b. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 2. Analysis of experimental results. J. Am. Chem. Soc. 104: 4559-4570.
40. Mandel, A.M., Akke, M., and Palmer III, A.G. 1995. Backbone dynamics of Escherichia coli ribonuclease HI: Correlations with structure and function in an active enzyme. J. Mol. Biol. 246: 144-163.
41. Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., and Mucke, L. 2000. Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders. Science 287: 1265-1269.
42. Murphy, D.D., Rueter, S.M., Trojanowski, J.Q., and Lee, V.M. 2000. Synucleins are developmentally expressed, and α-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20: 3214-3220.
43. Murray, I.V., Giasson, B.I., Quinn, S.M., Koppaka, V., Axelsen, P.H., Ischiropoulos, H., Trojanowski, J.Q., and Lee, V.M. 2003. Role of α-synuclein carboxy-terminus on fibril formation in vitro. Biochemistry 42: 8530-8540.
44. Nakajo, S., Tsukada, K., Omata, K., Nakamura, Y., and Nakaya, K. 1993. A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. Eur. J. Biochem. 217: 1057-1063.
45. Nakajo, S., Shioda, S., Nakai, Y., and Nakaya, K. 1994. Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization. Brain Res. Mol. Brain Res. 27: 81-86.
46. Narhi, L., Wood, S.J., Steavenson, S., Jiang, Y., Wu, G.M., Anafi, D., Kaufman, S.A., Martin, F., Sitney, K., Denis, P., et al. 1999. Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J. Biol. Chem. 274: 9843-9846.
47. 2+ binding to α-synuclein regulates ligand binding and oligomerization. J. Biol. Chem. 276: 22680-22684.
48. Park, J.Y. and Lansbury Jr., P.T. 2003. β-Synuclein inhibits formation of α-synuclein protofibrils: A possible therapeutic strategy against Parkinson's disease. Biochemistry 42: 3696-3700.
49. Payton, J.E., Perrin, R.J., Woods, W.S., and George, J.M. 2004. Structural determinants of PLD2 inhibition by α-synuclein. J. Mol. Biol. 337: 1001-1009.
50. Perez, R.G. and Hastings, T.G. 2004. Could a loss of α-synuclein function put dopaminergic neurons at risk? J. Neurochem. 89: 1318-1324.
51. Perrin, R.J., Woods, W.S., Clayton, D.F., and George, J.M. 2000. Interaction of human α-synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. J. Biol. Chem. 275: 34393-34398.
52. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. 1997. Mutation in the α-synuclein gene identified in families with Parkinson's disease. [see comments] Science 276: 2045-2047.
53. Schluter, O.M., Fornai, F., Alessandri, M.G., Takamori, S., Geppert, M., Jahn, R., and Sudhof, T.C. 2003. Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. Neuroscience 118: 985-1002.
54. Sidhu, A., Wersinger, C., and Vernier, P. 2004. Does α-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J. 18: 637-647.
55. Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. 2003. α-Synuclein locus triplication causes Parkinson's disease. Science 302: 841.
56. Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M., and Goedert, M. 1998. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. 95: 6469-6473.
57. Tjandra, N., Feller, S.E., Pastor, R.W., and Bax, A. 1995. Rotational diffusion anisotropy of human ubiquitin from 15N NMR relaxation. J. Am. Chem. Soc. 117: 12562-12566.
58. Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D.A., Kondo, J., Ihara, Y., and Saitoh, T. 1993. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. 90: 11282-11286.
59. Ulmer, T.S., Bax, A., Cole, N.B., and Nussbaum, R.L. 2005. Structure and dynamics of micelle-bound human α-synuclein. J. Biol. Chem. 280: 9595-9603.
60. Uversky, V.N., Li, J., Souillac, P., Millett, I.S., Doniach, S., Jakes, R., Goedert, M., and Fink, A.L. 2002. Biophysical properties of the synucleins and their propensities to fibrillate: Inhibition of α-synuclein assembly by β- and γ-synucleins. J. Biol. Chem. 277: 11970-11978.
61. Vuister, G.W. and Bax, A. 1993. Quantitative J correlation: A new approach for measuring homonuclear three-bond (JHNHa) coupling constants in 15N-enriched proteins. J. Am. Chem. Soc. 115: 7772-7777.
62. Weinreb, P.H., Zhen, W., Poon, A.W., Conway, K.A., and Lansbury Jr., P.T. 1996. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35: 13709-13715.
63. Wishart, D.S. and Case, D.A. 2002. Use of chemical shifts in macromolecular structure determination. Methods Enzymol. 338: 3-34.
64. Wuthrich, K. 1986. NMR of proteins and nucleic acids. J. Wiley & Sons, New York.
65. Yao, J., Dyson, H.J., and Wright, P.E. 1997. Chemical shift dispersion and secondary structure prediction in unfolded and partly folded proteins. FEBS Lett. 419: 285-289.
66. Yu, S., Ueda, K., and Chan, P. 2005. α-Synuclein and dopamine metabolism. Mol. Neurobiol. 31: 243-254.
67. Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B., et al. 2004. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55: 164-173.